All sponsors

Shenzhen TargetRx Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING2
READOUTS ≤12 MONTHS0
Open Shenzhen TargetRx Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
TGRX-326
NCT05955391
P2Active, not recruitingNon-small Cell Lung Cancer1642024-12-29 (+10 mo)
TGRX-814
NCT06206174
P1/2RecruitingHematologic Malignancy; Non Hodgkin Lymphoma302025-02-28
TGRX-326
NCT06082635
P3Active, not recruitingNon Small Cell Lung Cancer3212026-04-30 (+16 mo)
TGRX-678
NCT06453902
P2RecruitingChronic Myeloid Leukemia; Accelerated Phase CML402026-06-30
TGRX-678
NCT07489755
P3Not yet recruitingChronic Myelogenous Leukemia; Chronic Myelogenous Leukemia - Chronic Phase1802030-05-01